
Crane Company (CR) Stock Forecast & Price Target
Crane Company (CR) Analyst Ratings
Bulls say
Crane's diversified industrial portfolio has demonstrated strong performance, highlighted by a 5.6% year-over-year organic sales increase and a 16% rise in organic backlog, resulting in a total backlog of $1.44 billion. The company's growth is further supported by significant demand in its cryogenic and power businesses, particularly related to data center infrastructure and advancements in aerospace technologies. Additionally, strategic positioning in valuable programs, like the LTAMDS radar system, alongside recent large pharmaceutical orders, underscores Crane's capability to leverage market opportunities effectively, enhancing its long-term financial outlook.
Bears say
Crane's recent performance reflects significant challenges within its Process Flow Technologies (PFT) segment, which experienced a 1.5% decline in organic sales during the fourth quarter of 2025 and a lackluster outlook due to weakened demand in the chemical sector, particularly in Europe, China, and APAC regions. Despite a year-over-year backlog increase of 17% and solid performance in the Aerospace and Advanced Technologies (A&E) segment, the overall inbound organic orders dropped 4% year-over-year, indicating a cautious demand environment that may hinder future growth prospects. The tempered core growth assumption for 2026, driven by a slow start within PFT and rising inflationary pressures, suggests that Crane may face significant headwinds, impacting its revenue potential and overall financial health in the coming quarters.
This aggregate rating is based on analysts' research of Crane Company and is not a guaranteed prediction by Public.com or investment advice.
Crane Company (CR) Analyst Forecast & Price Prediction
Start investing in Crane Company (CR)
Order type
Buy in
Order amount
Est. shares
0 shares